Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 11601-11650 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05418816
SelfWrap-Assisted Arteriovenous Fistulas
NA
Active, not recruiting
20 participants
Started: Jun 14, 2021 · Completed: Sep 30, 2026
17 conditions
1 sponsor
1 location
NCT04258813
Onco-primary Care Networking to Support TEAM-based Care
NA
Active, not recruiting
313 participants
Started: Jun 14, 2021 · Completed: Jun 30, 2026
18 conditions
1 sponsor
1 location
NCT04891757
FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies
PHASE1
Active, not recruiting
144 participants
Started: Jun 14, 2021 · Completed: Jun 30, 2027
7 conditions
1 sponsor
5 locations
NCT04777539
Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
N/A
Active, not recruiting
279 participants
Started: Jun 14, 2021 · Completed: May 15, 2025
1 condition
2 sponsors
24 locations
NCT04247191
Parent Intervention to Reduce College Student Drinking and Consequences
NA
Active, not recruiting
2,061 participants
Started: Jun 14, 2021 · Completed: May 31, 2028
4 conditions
3 sponsors
1 location
NCT04768972
FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
PHASE3
Active, not recruiting
89 participants
Started: Jun 14, 2021 · Completed: Mar 31, 2028
1 condition
1 sponsor
25 locations
NCT04970134
Spanish Study for Molecular Characterization of Thyroid Carcinoma
N/A
Active, not recruiting
150 participants
Started: Jun 14, 2021 · Completed: Mar 31, 2025
2 conditions
1 sponsor
12 locations
NCT04956770
Study on Feasibility of Targeted Epidural Spinal Stimulation (TESS) to Improve Mobility in Patients With Parkinson's Disease
NA
Active, not recruiting
2 participants
Started: Jun 14, 2021 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT04846920
A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)
PHASE1
Active, not recruiting
52 participants
Started: Jun 14, 2021 · Completed: Jul 21, 2026
1 condition
1 sponsor
4 locations
NCT04746859
Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program
NA
Active, not recruiting
268 participants
Started: Jun 14, 2021 · Completed: Apr 30, 2025
2 conditions
9 sponsors
3 locations
NCT05051657
Evaluation of the Express Plus Range
NA
Active, not recruiting
28 participants
Started: Jun 14, 2021 · Completed: Apr 30, 2026
6 conditions
1 sponsor
6 locations
NCT04465721
TREAT to Improve Cardiometabolic Health
NA
Active, not recruiting
57 participants
Started: Jun 14, 2021 · Completed: Jun 30, 2026
2 conditions
4 sponsors
1 location
NCT04386135
DESVELA. Personal Skills as Determinants of Morbidity, Lifestyles, Quality of Life, Use of Services and Mortality.
N/A
Active, not recruiting
3,260 participants
Started: Jun 12, 2021 · Completed: Dec 31, 2025
9 conditions
19 sponsors
20 locations
NCT04676477
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
246 participants
Started: Jun 11, 2021 · Completed: Apr 30, 2027
1 condition
3 sponsors
31 locations
NCT04784429
Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population
NA
Active, not recruiting
107 participants
Started: Jun 11, 2021 · Completed: Dec 31, 2026
3 conditions
2 sponsors
90 locations
NCT04842877
Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma
PHASE2
Active, not recruiting
141 participants
Started: Jun 11, 2021 · Completed: Oct 31, 2026
1 condition
2 sponsors
22 locations
NCT04979455
Risk Factors for Exertional Heat Illness
N/A
Active, not recruiting
783 participants
Started: Jun 11, 2021 · Completed: Jul 31, 2025
1 condition
8 sponsors
1 location
NCT04613128
The PROMISE Pediatric Study 6 to 11 Years Old
N/A
Active, not recruiting
180 participants
Started: Jun 11, 2021 · Completed: Dec 19, 2025
2 conditions
2 sponsors
20 locations
NCT05066542
Recreational Basketball to Increase Participation in Diabetes Prevention
NA
Active, not recruiting
60 participants
Started: Jun 11, 2021 · Completed: Mar 30, 2026
2 conditions
1 sponsor
1 location
NCT04940507
BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial
NA
Active, not recruiting
50 participants
Started: Jun 10, 2021 · Completed: Dec 31, 2026
2 conditions
3 sponsors
1 location
NCT04739800
Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
PHASE2
Active, not recruiting
120 participants
Started: Jun 10, 2021 · Completed: Jun 14, 2026
50 conditions
2 sponsors
393 locations
NCT04848779
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
N/A
Active, not recruiting
16 participants
Started: Jun 10, 2021 · Completed: Oct 28, 2026
1 condition
1 sponsor
15 locations
NCT04687020
Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
PHASE4
Active, not recruiting
9 participants
Started: Jun 10, 2021 · Completed: Oct 31, 2032
1 condition
1 sponsor
5 locations
NCT04898153
First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft
NA
Active, not recruiting
20 participants
Started: Jun 10, 2021 · Completed: Sep 30, 2027
2 conditions
1 sponsor
6 locations
NCT04876456
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
PHASE2
Active, not recruiting
50 participants
Started: Jun 10, 2021 · Completed: Jan 31, 2027
4 conditions
3 sponsors
1 location
NCT04739527
Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment
PHASE1
Active, not recruiting
17 participants
Started: Jun 10, 2021 · Completed: Jun 1, 2026
1 condition
2 sponsors
1 location
NCT04706598
Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
PHASE1/PHASE2
Active, not recruiting
25 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2024
2 conditions
2 sponsors
4 locations
NCT04805866
Tracking Neural Synergies After Stroke.
N/A
Active, not recruiting
36 participants
Started: Jun 9, 2021 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT04913337
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PHASE1/PHASE2
Active, not recruiting
179 participants
Started: Jun 9, 2021 · Completed: Jul 31, 2025
15 conditions
2 sponsors
27 locations
NCT04901702
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
PHASE1/PHASE2
Active, not recruiting
46 participants
Started: Jun 9, 2021 · Completed: Dec 31, 2025
22 conditions
3 sponsors
10 locations
NCT05380440
Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR
NA
Active, not recruiting
240 participants
Started: Jun 9, 2021 · Completed: Aug 31, 2025
4 conditions
1 sponsor
1 location
NCT04864067
No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer
PHASE2
Active, not recruiting
73 participants
Started: Jun 9, 2021 · Completed: Mar 1, 2026
1 condition
1 sponsor
3 locations
NCT04897009
Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer
N/A
Active, not recruiting
38 participants
Started: Jun 9, 2021 · Completed: Jun 8, 2026
1 condition
2 sponsors
1 location
NCT04679870
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
PHASE2
Active, not recruiting
21 participants
Started: Jun 9, 2021 · Completed: Jun 30, 2026
1 condition
2 sponsors
11 locations
NCT04720157
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC
PHASE3
Active, not recruiting
1,145 participants
Started: Jun 9, 2021 · Completed: Feb 11, 2027
1 condition
3 sponsors
166 locations
NCT04558866
Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
PHASE2
Active, not recruiting
51 participants
Started: Jun 9, 2021 · Completed: Jun 30, 2025
1 condition
2 sponsors
6 locations
NCT04464980
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
PHASE2
Active, not recruiting
1,516 participants
Started: Jun 8, 2021 · Completed: Jan 31, 2027
1 condition
7 sponsors
21 locations
NCT04881019
PRediction Of Glycemic RESponse Study
N/A
Active, not recruiting
1,070 participants
Started: Jun 8, 2021 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT04765345
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F
N/A
Active, not recruiting
44 participants
Started: Jun 8, 2021 · Completed: Jun 30, 2027
3 conditions
4 sponsors
10 locations
NCT04746924
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
PHASE3
Active, not recruiting
662 participants
Started: Jun 8, 2021 · Completed: Mar 31, 2026
2 conditions
1 sponsor
218 locations
NCT04225585
Well-Being After Breast Cancer Surgery
NA
Active, not recruiting
316 participants
Started: Jun 8, 2021 · Completed: Mar 31, 2026
2 conditions
2 sponsors
2 locations
NCT04877691
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
PHASE3
Active, not recruiting
367 participants
Started: Jun 8, 2021 · Completed: Nov 18, 2026
1 condition
2 sponsors
140 locations
NCT04647916
Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
PHASE2
Active, not recruiting
44 participants
Started: Jun 8, 2021 · Completed: Dec 31, 2028
5 conditions
3 sponsors
296 locations
NCT04481113
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
PHASE1
Active, not recruiting
8 participants
Started: Jun 7, 2021 · Completed: Dec 30, 2025
20 conditions
4 sponsors
1 location
NCT04596514
Resuscitative Endovascular Balloon Occlusion of the Aorta in Non-traumatic Out of Hospital Cardiac Arrest
NA
Active, not recruiting
200 participants
Started: Jun 7, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
11 locations
NCT04815187
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
PHASE4
Active, not recruiting
39 participants
Started: Jun 7, 2021 · Completed: Dec 31, 2025
3 conditions
2 sponsors
2 locations
NCT04837222
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
N/A
Active, not recruiting
1,000 participants
Started: Jun 7, 2021 · Completed: Jun 19, 2026
1 condition
1 sponsor
32 locations
NCT04709276
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
PHASE2
Active, not recruiting
41 participants
Started: Jun 7, 2021 · Completed: Aug 31, 2028
2 conditions
2 sponsors
3 locations
NCT04879628
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
PHASE2
Active, not recruiting
129 participants
Started: Jun 7, 2021 · Completed: Aug 23, 2027
1 condition
1 sponsor
37 locations
NCT04875195
A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)
PHASE2
Active, not recruiting
66 participants
Started: Jun 7, 2021 · Completed: Oct 13, 2025
2 conditions
1 sponsor
27 locations
Previous
1
More pages
230
231
232
233
234
235
236
More pages
431
Next